Hereditary prostate cancer - primetime for genetic testing?
Prostate cancer (PCa) is the most prevalent cancer in men and one of the predominant causes of death among men in European countries [1]. While most PCa remain localized, a subset will be aggressive, leading to metastasis formation associated with significant morbidity and mortality. Thus, one major issue in PCa research is to early detect those patients who are likely to harbor an aggressive variant of PCa at young age importantly needing an active anti-cancer treatment.
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Isabel Heidegger, Igor Tsaur, Hendrik Borgmann, Christian Surcel, Alexander Kretschmer, Romain Mathieu, Pieter De Visschere, Massimo Valerio, Roderick C.N. van den Bergh, Piet Ost, Derya Tilki, Giorgio Gandaglia, Guillaume Ploussard, on behalf of the EAU- Tags: Hot Topic Source Type: research